Asset
VK-2809
Ligand Pharmaceuticals Incorporated Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00879112 | phase2 | withdrawn | 2009-04-01 | 2009-12-01 | Ligand Pharmaceuticals | Study of MB07811 in Subjects With Hypercholesterolemia |
FDA applications (0)
This company has no applications containing this asset.